Agenda for the 2024 Cannabinoids in Clinical Practice Conference
| April 30, 2024 | ||
| 8:45-9:45 | Registration & Breakfast *Unaccredited Sponsored Presentation (9:15-9:45) | |
| 9:45-10:00 | Updates and any sponsor acknowledgements | |
| 10:00-10:30 | Cannabis, endocannabinoids and PTSD | Matthew Hill, PhD |
| 10:30-11:00 | Central actions of cannabis in neuropathic pain | Tuan Trang, PhD |
| 11:00-11:30 | Health and Coffee Break | |
| 11:30-12:00 | Are minor cannabinoids intoxicating? Comparing plant cannabinoids to THC in mouse models | Robert Laprairie, PhD |
| 12:00-12:30 | The interface of nociplastic pain and cannabinoid-based medicines: do cannabinoids hold the key? | Mary Ann Fitzcharles, MD, FRCP |
| 12:30-12:45 | Fatty acid amide hydrolase levels in social anxiety disorder: A replication PET study with the tracer [11C]CURB | Christina Pereira, PhD |
| 12:45-1:15 | Opioid-sparing effects of cannabinoids | Bernard Le Foll, MD, PhD, MCFPere |
| 1:15-2:00 | Lunch | |
| 2:00-2:30 | Poster Session (Unaccredited Session)** | |
| 2:30-3:00 | Exploring early-life trauma, current stress, and problematic cannabis use in a young adult population | Zachary Patterson, PhD |
| 3:00-3:15 | Safety of cannabinoids used for medical purposes in children: A systematic review and meta-analysis | Manik Chhabra, PhD Candidate |
| 3:15-4:00 | Clinician's Panel Discussion: Focus on Pain Conditions | |
| 4:00 | Closing Remarks |
**Learning activities used by a physician to enhance their awareness of new evidence, perspectives or discoveries that are potentially relevant to their professional practice, such as poster presentations, may be claimed as a scanning activity under Section 2. You may claim 0.5 credits per poster